These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28231029)

  • 1. Unintended Insulin Pump Delivery in Hyperbaric Conditions.
    Bertuzzi F; Pintaudi B; Bonomo M; Garuti F
    Diabetes Technol Ther; 2017 Apr; 19(4):265-268. PubMed ID: 28231029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in altitude cause unintended insulin delivery from insulin pumps: mechanisms and implications.
    King BR; Goss PW; Paterson MA; Crock PA; Anderson DG
    Diabetes Care; 2011 Sep; 34(9):1932-3. PubMed ID: 21816978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin pumps and drop in pressure].
    Aanderud L; Hansen EM
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):570-2. PubMed ID: 8209340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bubble formation occurs in insulin pumps in response to changes in ambient temperature and atmospheric pressure but not as a result of vibration.
    Lopez PE; King BR; Goss PW; Chockalingam G
    BMJ Open Diabetes Res Care; 2014; 2(1):e000036. PubMed ID: 25452873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pumps: from inception to the present and toward the future.
    Alsaleh FM; Smith FJ; Keady S; Taylor KM
    J Clin Pharm Ther; 2010 Apr; 35(2):127-38. PubMed ID: 20456732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    J Diabetes Sci Technol; 2018 May; 12(3):608-613. PubMed ID: 29284290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of hyperbaric on human attention functions based on eye movements recorded using an infrared camera.
    Barski M; Jermakow N; Barska K; Siewiera J
    Adv Clin Exp Med; 2023 Dec; 32(12):1385-1392. PubMed ID: 37589224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of infusion pumps during hyperbaric conditions.
    Lavon H; Shupak A; Tal D; Ziser A; Abramovich A; Yanir Y; Shoshani O; Gil A; Leiba R; Nachum Z
    Anesthesiology; 2002 Apr; 96(4):849-54. PubMed ID: 11964591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes.
    Mathiesen JM; Secher AL; Ringholm L; Nørgaard K; Hommel E; Andersen HU; Damm P; Mathiesen ER
    J Matern Fetal Neonatal Med; 2014 May; 27(7):724-8. PubMed ID: 23981186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended insulin delivery using Omnipod DASH during a high-altitude flight.
    Shah M; Hadian Y; Peltsverger M; Crane J
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35314435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Carefusion Alaris PC infusion pump for hyperbaric oxygen therapy conditions: Technical report.
    Smale A; Tsouras T
    Undersea Hyperb Med; 2017; 44(1):17-25. PubMed ID: 28768081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hyperbaric exposure on eyes with intraocular gas bubbles.
    Jackman SV; Thompson JT
    Retina; 1995; 15(2):160-6. PubMed ID: 7624606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infusion rate of most disposable, non-electric infusion pumps decreases under hypobaric conditions.
    Mizuuchi M; Yamakage M; Iwasaki S; Kimura A; Namiki A
    Can J Anaesth; 2003; 50(7):657-62. PubMed ID: 12944439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative dose accuracy of durable and patch insulin infusion pumps.
    Jahn LG; Capurro JJ; Levy BL
    J Diabetes Sci Technol; 2013 Jul; 7(4):1011-20. PubMed ID: 23911184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Hospira Plum A+ (HB) hyperbaric infusion pump.
    Bell J; Weaver LK; Deru K
    Undersea Hyperb Med; 2014; 41(3):235-43. PubMed ID: 24984319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.